This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Pfizer Corporation, Amgen Fremont Inc., Bristol-Myers Squibb Compnay. Active years: 2009-2017.
Company Filing History:


Years Active: 2009-2017
Title: Innovations and Contributions of Inventor Xin Jiang
Introduction
Xin Jiang is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 6 patents to his name, his work has the potential to impact the diagnosis and treatment of various diseases.
Latest Patents
Among his latest patents, Xin Jiang has developed compositions comprising anti-transthyretin antibodies. These compositions are particularly useful for the diagnosis, prognosis, and treatment of amyloid diseases or symptoms thereof. Another notable patent involves human monoclonal antibodies to activin receptor-like kinase-1. This invention relates to antibodies that bind to the extracellular domain of activin receptor-like kinase-1 and function to abrogate the ALK-1/TGF-beta-1/Smad1 signaling pathway. The invention also includes methods of making these antibodies and compositions, as well as transgenic animals or plants that incorporate the relevant nucleic acid molecules.
Career Highlights
Xin Jiang has worked with leading companies in the biotechnology sector, including Pfizer Corporation and Amgen Fremont Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field.
Collaborations
Throughout his career, Xin Jiang has collaborated with notable professionals, including Michael Aidan North and Dana Dan Hu-Lowe. These collaborations have further enhanced his research and development efforts.
Conclusion
Xin Jiang's innovative work in the field of biotechnology, particularly in the development of therapeutic antibodies, showcases his significant contributions to medical science. His patents and collaborations reflect a commitment to advancing healthcare solutions.